Cargando…
Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Radcliffe Cardiology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955741/ https://www.ncbi.nlm.nih.gov/pubmed/31933693 http://dx.doi.org/10.15420/ecr.2019.14.3.CG1 |
| _version_ | 1783486998127837184 |
|---|---|
| author | Tamargo, Juan |
| author_facet | Tamargo, Juan |
| author_sort | Tamargo, Juan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6955741 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Radcliffe Cardiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69557412020-01-13 Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments Tamargo, Juan Eur Cardiol Corrigendum Radcliffe Cardiology 2019-12-18 /pmc/articles/PMC6955741/ /pubmed/31933693 http://dx.doi.org/10.15420/ecr.2019.14.3.CG1 Text en Copyright © 2019, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
| spellingShingle | Corrigendum Tamargo, Juan Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments |
| title | Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments |
| title_full | Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments |
| title_fullStr | Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments |
| title_full_unstemmed | Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments |
| title_short | Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments |
| title_sort | corrigendum to: sodium–glucose cotransporter 2 inhibitors in heart failure: potential mechanisms of action, adverse effects and future developments |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955741/ https://www.ncbi.nlm.nih.gov/pubmed/31933693 http://dx.doi.org/10.15420/ecr.2019.14.3.CG1 |
| work_keys_str_mv | AT tamargojuan corrigendumtosodiumglucosecotransporter2inhibitorsinheartfailurepotentialmechanismsofactionadverseeffectsandfuturedevelopments |